US1280583022

Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.

March 06, 2026 18:15 ET  | Source: Lisata Therapeutics, Inc. Each Lisata stockholder to receive $5.00 per share in cash…

4 hours ago